BEIJING, March 25 Sinovac Biotech Ltd. (Amex: SVA),a leading provider of vaccines in China, today announced that it will host aconference call on Monday, March 31, 2008 at 9:00 a.m. ET to review theCompany's fourth quarter and year ended December 31, 2007 financial resultsand provide an update on recent corporate developments.
To access the conference call, please dial 1-877-407-4018 (USA) or 1-201-689-8471 (international). A replay of the call will be available from 12:00p.m. ET on March 31, until April 14, 2008 at midnight. To access the replay,please dial 1-877-660-6853 (USA) or 1-201-612-7415 (international) andreference the account number 3055 and the access code 279686.
A live audio webcast of the call will also be available from the Investorssection on the corporate web site at http://www.sinovac.com . A webcast replaycan be accessed on the corporate website beginning March 31, 2008 and thereplay will remain available for 30 days.
Sinovac Biotech Ltd. is a China-based biopharmaceutical company thatfocuses on the research, development, manufacture and commercialization ofvaccines that protect against human infectious diseases. Sinovac's vaccinesinclude HealiveTM (hepatitis A), BiliveTM (combined hepatitis A and B) andAnfluTM (influenza). Sinovac is currently developing human vaccines againstthe H5N1 strain of pandemic influenza, Japanese encephalitis and SARS.Additional information about Sinovac is available on its website,http://www.sinovac.com . To be added to our distribution list, please email:[email protected]
more information, please contact: Contact Information: Helen G. Yang Sinovac Biotech Ltd. Tel: +86-10-8289-0088 Ext. 871 Fax: +86-10-6296-6910 Email: [email protected]
Investors / Media: Stephanie Carrington / Janine McCargo The Ruth Group Tel: 646-536-7017/7033 Email: [email protected]
/ [email protected]
SOURCE Sinovac Biotech Ltd.